Enlivex plans to raise $212 million to purchase Rain tokens, aiming to create a digital asset vault for prediction markets.

Nasdaq-listed biopharmaceutical company Enlivex Therapeutics announced that it will raise $212 million through a PIPE private placement to purchase Rain tokens (RAIN) as the core reserve for its Digital Asset Vault (DAT), stating that the project is the first DAT built around a prediction market token.